Repro Med Systems Inc (KRMD) - Total Liabilities
Based on the latest financial reports, Repro Med Systems Inc (KRMD) has total liabilities worth $10.64 Million USD as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Repro Med Systems Inc (KRMD) cash conversion ratio to assess how effectively this company generates cash.
Repro Med Systems Inc - Total Liabilities Trend (1996–2024)
This chart illustrates how Repro Med Systems Inc's total liabilities have evolved over time, based on quarterly financial data. Check Repro Med Systems Inc liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Repro Med Systems Inc Competitors by Total Liabilities
The table below lists competitors of Repro Med Systems Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Sinphar Pharmaceutical Co Ltd
TW:1734
|
Taiwan | NT$2.44 Billion |
|
Hawesko Holding AG
XETRA:HAW
|
Germany | €301.92 Million |
|
OrganiGram Holdings Inc
TO:OGI
|
Canada | CA$161.22 Million |
|
Frauenthal Holding AG
VI:FKA
|
Austria | €287.92 Million |
|
Starrag Group Holding AG
SW:STGN
|
Switzerland | CHF211.96 Million |
|
Eastech Holding Limited
TW:5225
|
Taiwan | NT$3.79 Billion |
|
Oriental Interest Bhd
KLSE:5827
|
Malaysia | RM931.03 Million |
|
Gulf Island Fabrication Inc
NASDAQ:GIFI
|
USA | $52.42 Million |
Liability Composition Analysis (1996–2024)
This chart breaks down Repro Med Systems Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Repro Med Systems Inc (KRMD) market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.48 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.65 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.39 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Repro Med Systems Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Repro Med Systems Inc (1996–2024)
The table below shows the annual total liabilities of Repro Med Systems Inc from 1996 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $10.40 Million | +28.34% |
| 2023-12-31 | $8.11 Million | -26.34% |
| 2022-12-31 | $11.01 Million | +129.69% |
| 2021-12-31 | $4.79 Million | +27.38% |
| 2020-12-31 | $3.76 Million | +42.19% |
| 2019-12-31 | $2.65 Million | +67.01% |
| 2018-12-31 | $1.58 Million | -1.67% |
| 2017-12-31 | $1.61 Million | +7.83% |
| 2016-12-31 | $1.49 Million | +5.03% |
| 2015-12-31 | $1.42 Million | +41.18% |
| 2014-12-31 | $1.01 Million | -0.90% |
| 2013-12-31 | $1.02 Million | -17.71% |
| 2012-12-31 | $1.24 Million | -1.50% |
| 2011-12-31 | $1.25 Million | +31.13% |
| 2010-12-31 | $956.63K | -29.51% |
| 2009-12-31 | $1.36 Million | -15.47% |
| 2008-12-31 | $1.61 Million | -9.93% |
| 2007-12-31 | $1.78 Million | -0.11% |
| 2006-12-31 | $1.78 Million | +20.01% |
| 2005-12-31 | $1.49 Million | +6.72% |
| 2004-12-31 | $1.39 Million | +2.31% |
| 2003-12-31 | $1.36 Million | +29.75% |
| 2002-12-31 | $1.05 Million | -1.17% |
| 2001-12-31 | $1.06 Million | +41.76% |
| 2000-12-31 | $749.03K | -18.29% |
| 1999-12-31 | $916.66K | -48.50% |
| 1998-12-31 | $1.78 Million | -17.59% |
| 1997-12-31 | $2.16 Million | +83.05% |
| 1996-12-31 | $1.18 Million | -- |
About Repro Med Systems Inc
KORU Medical Systems, Inc. develops, manufactures, and commercializes subcutaneous infusion solutions primarily for the subcutaneous drug delivery market in the United States and internationally. The company offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases (PIDD), chronic inflammatory demyelinating p… Read more